SSAGE Page Proof Instructions and Queries Journal Title: SLAS DIscovery Article Number: 690483 Greetings, and thank you for publishing with SAGE. We have prepared this page proof for your review. Please respond to each of the below queriesbydigitallymarkingthisPdfusingAdobeReader(freeathttps://get.adobe.com/reader) Please use only the circled tools to indicate your requests and responses, as edits via other tools/ methods are not compatible with our software.To ask a question or request a formatting change(such as italics), please click the tool and then choose"Text Callout. To access the necessary tools, choose"Comment"from the right-side menu. om1②@@T回②吕圆國 Oue Please confirm that all author information, including names, affiliations, sequence, and contact details, is correct. Please review the entire document for typographical errors, mathematical errors, and any other necessary corrections: check headings, tables, and figures. Please confirm that you have completely and properly reviewed all details of your proof, responded to any/all queries, and that you understand this is your FINAL opportunity to review your article before publication. Oversights will require publication of a corrigendum, which is not advisable Please confirm that the Funding and Conflict of Interest statements are accurate. Please provide the manufacturer and city and state or country for Chromas Lite software 2 Please provide the manufacturer and city and state or country for Insight Il 3 Please provide city and state or country for Clontech and GE Healthcare Bio-Sciences where indicated by Xxx pLease define"PFA" s Please list cities for Abcam and Takara where indicated by XXX 6Please clarify"IL-4, IL-5, and IL-6 known to be associated with isotype switching to secretory IgA, oral immunization with]" 7 Please provide any acknowledgments that do not relate to funding Please clarify "was determined CCK-8 reagentPage Proof Instructions and Queries Greetings, and thank you for publishing with SAGE. We have prepared this page proof for your review. Please respond to each of the below queries by digitally marking this PDF using Adobe Reader (free at https://get.adobe.com/reader). Please use only the circled tools to indicate your requests and responses, as edits via other tools/methods are not compatible with our software. To ask a question or request a formatting change (such as italics), please click the tool and then choose “Text Callout.” To access the necessary tools, choose “Comment” from the right-side menu. No. Query No queries Journal Title: SLAS Discovery Article Number: 690483 Please confirm that all author information, including names, affiliations, sequence, and contact details, is correct. Please review the entire document for typographical errors, mathematical errors, and any other necessary corrections; check headings, tables, and figures. Please confirm that you have completely and properly reviewed all details of your proof, responded to any/all queries, and that you understand this is your FINAL opportunity to review your article before publication. Oversights will require publication of a corrigendum, which is not advisable. Please confirm that the Funding and Conflict of Interest statements are accurate. 1 Please provide the manufacturer and city and state or country for Chromas Lite software 2 Please provide the manufacturer and city and state or country for Insight II 3 Please provide city and state or country for Clontech and GE Healthcare Bio-Sciences where indicated by XXX 4 Please define “PFA” 5 Please list cities for Abcam and Takara where indicated by XXX 6 Please clarify “IL-4, IL-5, and IL-6 known to be associated with isotype switching to secretory IgA, oral immunization with Gb-1” 7 Please provide any acknowledgments that do not relate to funding 8 Please clarify “was determined CCK-8 reagent” 690483JBX